FI57752C - Foerfarande foer framstaellning av pao centralnervsystemet verkande 4-fenyl-5-amino-etyl-4-oxazolin-2-onderivat eller dess farmaceutiskt godtagbara salter - Google Patents
Foerfarande foer framstaellning av pao centralnervsystemet verkande 4-fenyl-5-amino-etyl-4-oxazolin-2-onderivat eller dess farmaceutiskt godtagbara salter Download PDFInfo
- Publication number
- FI57752C FI57752C FI3183/73A FI318373A FI57752C FI 57752 C FI57752 C FI 57752C FI 3183/73 A FI3183/73 A FI 3183/73A FI 318373 A FI318373 A FI 318373A FI 57752 C FI57752 C FI 57752C
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- oxazolin
- solution
- ethyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3053672 | 1972-10-16 | ||
| IT3053672 | 1972-10-16 | ||
| IT2811573 | 1973-08-22 | ||
| IT2811573A IT1056733B (it) | 1973-08-22 | 1973-08-22 | 4 aril 5 aminoalohil 4 ossazolin 2 oni loro derivati e processi per la loro preparazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI57752B FI57752B (fi) | 1980-06-30 |
| FI57752C true FI57752C (fi) | 1980-10-10 |
Family
ID=26328766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI3183/73A FI57752C (fi) | 1972-10-16 | 1973-10-15 | Foerfarande foer framstaellning av pao centralnervsystemet verkande 4-fenyl-5-amino-etyl-4-oxazolin-2-onderivat eller dess farmaceutiskt godtagbara salter |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3930008A (no) |
| JP (1) | JPS4993360A (no) |
| CA (1) | CA1016550A (no) |
| CH (1) | CH605859A5 (no) |
| DE (1) | DE2351948A1 (no) |
| DK (1) | DK135122B (no) |
| ES (1) | ES419632A1 (no) |
| FI (1) | FI57752C (no) |
| FR (1) | FR2202701B1 (no) |
| GB (1) | GB1429571A (no) |
| NL (1) | NL161154C (no) |
| NO (1) | NO140299C (no) |
| SE (1) | SE391717B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4123529A (en) * | 1976-04-23 | 1978-10-31 | Lilly Industries Limited | Phenylpiperazine derivatives |
| PT77428B (fr) * | 1982-10-05 | 1986-02-27 | Cortial | Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant |
| FR2546167B2 (fr) * | 1983-05-19 | 1985-07-12 | Cortial | Nouvelles amino-2 piperazino et piperidinomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique |
| CN1008735B (zh) | 1984-11-02 | 1990-07-11 | 拜尔公司 | 以取代的氮杂茂基甲基-环丙基-甲醇衍生物为活性成分的组合物 |
| US4728661A (en) * | 1985-11-13 | 1988-03-01 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic phenyl oxazolones |
| US6159990A (en) * | 1997-06-18 | 2000-12-12 | Synaptic Pharmaceutical Corporation | Oxazolidinones as α1A receptor antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3576808A (en) * | 1967-09-15 | 1971-04-27 | Miles Lab | N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones |
| JPS4922770A (no) * | 1972-06-22 | 1974-02-28 |
-
1973
- 1973-10-03 US US403275A patent/US3930008A/en not_active Expired - Lifetime
- 1973-10-11 CH CH1449973A patent/CH605859A5/xx not_active IP Right Cessation
- 1973-10-12 GB GB4787573A patent/GB1429571A/en not_active Expired
- 1973-10-15 SE SE7313966A patent/SE391717B/xx unknown
- 1973-10-15 CA CA183,418A patent/CA1016550A/en not_active Expired
- 1973-10-15 ES ES419632A patent/ES419632A1/es not_active Expired
- 1973-10-15 NO NO4002/73A patent/NO140299C/no unknown
- 1973-10-15 FI FI3183/73A patent/FI57752C/fi active
- 1973-10-15 NL NL7314147.A patent/NL161154C/xx not_active IP Right Cessation
- 1973-10-16 DK DK560273AA patent/DK135122B/da unknown
- 1973-10-16 JP JP48116238A patent/JPS4993360A/ja active Pending
- 1973-10-16 DE DE19732351948 patent/DE2351948A1/de not_active Withdrawn
- 1973-10-16 FR FR7336838A patent/FR2202701B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO140299B (no) | 1979-04-30 |
| GB1429571A (en) | 1976-03-24 |
| AU6121673A (en) | 1975-04-10 |
| FR2202701A1 (no) | 1974-05-10 |
| DK135122B (da) | 1977-03-07 |
| NO140299C (no) | 1979-08-08 |
| CA1016550A (en) | 1977-08-30 |
| US3930008A (en) | 1975-12-30 |
| CH605859A5 (no) | 1978-10-13 |
| NL7314147A (no) | 1974-04-18 |
| JPS4993360A (no) | 1974-09-05 |
| SE391717B (sv) | 1977-02-28 |
| FI57752B (fi) | 1980-06-30 |
| NL161154C (nl) | 1980-01-15 |
| DK135122C (no) | 1977-08-08 |
| DE2351948A1 (de) | 1974-04-25 |
| ES419632A1 (es) | 1976-06-16 |
| FR2202701B1 (no) | 1980-01-11 |
| NL161154B (nl) | 1979-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3514076C2 (no) | ||
| EA034169B1 (ru) | Синтез полициклических карбамоилпиридоновых соединений | |
| DE4342186A1 (de) | Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten | |
| PT85304B (pt) | Processo para a preparacao de derivados d difenil-profilamina | |
| FI57752C (fi) | Foerfarande foer framstaellning av pao centralnervsystemet verkande 4-fenyl-5-amino-etyl-4-oxazolin-2-onderivat eller dess farmaceutiskt godtagbara salter | |
| DD267047A5 (de) | Verfahren zur herstellung von pyrrolobenzimidazolen | |
| DD224851A5 (de) | Verfahren zur herstellung von imidazolen | |
| WO2015120111A2 (en) | Expedient synthesis of sitagliptin | |
| DE2505239C2 (no) | ||
| SU873887A3 (ru) | Способ получени производных имидазо/2,1-в/тиазолина или имидазо /2,1-в/тиазина или их кислотно-аддитивных солей,в виде смеси изомеров или отдельных изомеров | |
| WO2001057045A1 (de) | Neue positive allosterische ampa-rezeptor modulatoren (paarm), verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| PL117107B1 (en) | Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles-geksagirdid 1h-pirido 4,3-b ionidolov | |
| CH622248A5 (no) | ||
| JP2552494B2 (ja) | イミダゾチアジアジン誘導体及びその製造法 | |
| DE2413610A1 (de) | Neue heterocyclische verbindungen und verfahren zu deren herstellung | |
| DE69729631T2 (de) | Verfahren zur herstellung von granisetron | |
| DE69411852T2 (de) | Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten | |
| DE1115259B (de) | Verfahren zur Herstellung von Iminodibenzylen | |
| SE450704B (sv) | 3,7-diazabicyklo /3,3,1/ nonaner, forfarande for framstellning och farmaceutisk beredning derav | |
| US3354164A (en) | S-triazolo-[3, 4-a] isoquinolines and process | |
| US3071589A (en) | 3-benzyl-4-lower-alkyl-3, 4, 5, 6-tetrahydro-4-carboline quaternary ammonium salts and preparation thereof | |
| HU197843B (en) | Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide-n-oxide derivatives | |
| SE423387B (sv) | Sett att framstella 2-/(p-metoxibensoyl-hydrazon-formyl-kinoxalin-1,4-dioxid | |
| WO2006129781A1 (ja) | ジベンズオキセピン誘導体の製造方法 | |
| PL92579B1 (en) | Bis piperazino-androstanes - as muscle relaxants[FR2194434A1] |